Your session is about to expire
← Back to Search
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
65 years of age or older
Be older than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights
Study Summary
This trial will test if an adaptive reminder system can help older adults stick to home-based cognitive training better than a typical reminder system.
Who is the study for?
This trial is for older adults who are at least 65 years old with normal or corrected vision and can pass a dementia screening. It's not suitable for those with blindness, deafness, reading difficulties below the 6th-grade level, Parkinson's, Alzheimer's, other neurodegenerative diseases, terminal illness, severe motor issues or those not in Tallahassee for 6 months.Check my eligibility
What is being tested?
The study is testing if an adaptive and personalized reminder system (APPT) can improve adherence to home-based cognitive training compared to standard reminders among older adults. The goal is to see which method better supports regular participation in the training.See study design
What are the potential side effects?
Since this trial involves reminder systems rather than medications or invasive procedures, traditional side effects are not expected. Participants may experience frustration or stress related to technology use.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am 65 years old or older.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 6 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Adherence (holidays)
Adherence (session length)
Adherence (session number)
Secondary outcome measures
Busyness Scale (predictor of adherence)
Dementia Worry (predictor of adherence)
Objective Cognition (predictor of adherence)
+5 moreOther outcome measures
Interview
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Smart Adherence Support ConditionExperimental Treatment1 Intervention
To promote adherence, participants will receive reminders when home-based cognitive training has not been completed. This will be in the form of a text message to participants' smart phone. In this condition, participants will receive adaptive and tailored reminders based on dynamic algorithms that deploy reminders in a way that considers participant preferences, days and times of previous successful assessments, the success of previous reminder attempts, and answers to brief questions contained within reminder prompts. Parameter weights for these variables will be adjusted dynamically over a 6-month assessment period to ensure that reminders are deployed when they are most likely to be acted upon.
Group II: Reminder Only ConditionActive Control1 Intervention
To promote adherence, participants will receive generic reminders when home-based cognitive training has not been completed. This will be in the form of a text message to participants' smart phone.
Find a Location
Who is running the clinical trial?
Florida State UniversityLead Sponsor
199 Previous Clinical Trials
31,501 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have a history of Parkinson's, Alzheimer's, or another neurodegenerative disease.I have significant difficulty moving or controlling my movements.I am 65 years old or older.
Research Study Groups:
This trial has the following groups:- Group 1: Reminder Only Condition
- Group 2: Smart Adherence Support Condition
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
What is the maximum number of participants accepted into this clinical experiment?
"Affirmative. Clinicaltrials.gov attests that this study, which was first uploaded on June 1st 2022, is actively enrolling participants. A total of 190 individuals are sought from one medical centre."
Answered by AI
Is enrollment for this examination still open?
"Affirmative. Clinicaltrials.gov documents clearly indicate that this trial is still recruiting participants, with the first posting dated June 1st 2022 and the most recent update occuring on June 3rd 2022. 190 people must be recruited from a single site for full enrollment."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger